Search
for
Sort by
Research 541–570 of 1000+
- New Treatments for Hair Loss
- Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis
- Head and Neck Reconstruction
- Microneedling in Dermatology: A Review
- Skin eruptions specific to pregnancy: an overview
- Effect of intense pulsed light treatment on human skin<i>in vitro</i>: analysis of immediate effects on dermal papillae and hair follicle stem cells
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- Disorders of hair
- Evaluating Antiinflammatory and Antiandrogenic Effects of Garden Cress (Lepidium sativum L.) in HaCaT cells
- Acne in Dark Skin
- Endocrine disorders and hormonal therapy for adolescent acne
- Reply to ‘Frontal fibrosing alopecia’
- Immunosuppressive therapy in autoimmune disease — A review
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Effects of Topical application of Astragalus membranaceus in Spontaneous Alopecia Mice Model
- Botanicals With Dermatologic Properties Derived From First Nations Healing: Part 1—Trees
- Beneficial uses of Breadfruit (Artocarpus altilis)
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Central Centrifugal Cicatricial Alopecia
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Erosive Pustular Dermatosis of the Scalp
- Abstracts
- Acne in children
- Psychotropic Treatment of Psychodermatologic Disorders
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris
- Nanofibers: An Effective Biomedical Tool for Burn Management
- Treatment-Refractory Central Centrifugal Cicatricial Alopecia Responsive to a Novel Botanical Treatment
- Bio-Catalytic Action of Pseudomonas DL17 on Environmental Contaminant Sunset Yellow FCF
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata